Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination chemotherapy plus peripheral stem cell transplantation in patients with Stage III/IV ovarian canc…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [Phase 2]
This update describes a Phase 2 trial of a vaccine therapy for stage III or IV ovarian epithelial cancer. The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of docetaxel in patients with recurrent or refractory ovarian cancer or primary peritoneal cancer; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating capecitabine for recurrent ovarian epithelial cancer or primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [Phase 2]
Phase 2 trial of amifostine for gynecologic cancers has been terminated (including ovarian, primary peritoneal, fallopian tube, cervical, ut…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel for ovarian cancer and primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors [Phase 1]
Phase 1 safety study of XL147 (SAR245408) in combination with paclitaxel and carboplatin in adults with solid tumors has been completed, inv…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial of topotecan in unresectable gynecologic cancers has completed. The study included cervical, endometrial, fallopian tube, ovar…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
This clinical trial update notes completion of a study evaluating the development of the Peritoneal Carcinomatosis Index (PCI) in ovarian ca…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer [Phase 1]
Phase 1 study evaluating EGEN-001 in combination with carboplatin and docetaxel in recurrent platinum-sensitive ovarian cancer to assess saf…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer [Phase 2]
Phase 2 study assessing the efficacy of AZD2281 (olaparib) in platinum-sensitive relapsed serous ovarian cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors [Phase 2]
A Phase 2 study evaluating high-dose thiotepa followed by peripheral stem cell transplantation in patients with refractory solid tumors, whi…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Safety of Active Immunotherapy in Subjects With Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating the safety of an active immunotherapy in subjects with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer [Phase 1]
A Phase 1 safety study of phIL-12-005/PPC for recurrent ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetics of AGS-8M4 in adults with advanced ovarian cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of AGS-8M4 in combination with chemotherapy in women with ovarian cancer was termin…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1]
Phase I clinical trial evaluating an autologous dendritic cell vaccine in patients with recurrent ovarian cancer or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Melphalan in Patients With Neoplastic Meningitis [Phase 1]
Phase 1 trial of intrathecal melphalan in patients with neoplastic meningitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer [Phase 1]
A Phase 1 trial evaluating the combination of azacitidine, valproic acid, and carboplatin in patients with ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer [Phase 1]
A Phase 1 study evaluating the safety and pharmacokinetics of intraoperative hyperthermic intraperitoneal chemotherapy using cisplatin to tr…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers [Phase 1]
A Phase 1 clinical trial evaluating an infectivity-enhanced suicide gene expressing adenovirus for ovarian cancer and other gynecologic canc…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Clinical trial update describing a study investigating DNA in patients with ovarian epithelial cancer across all stages (Stage I through Sta…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated combining chemotherapy with peripheral stem cell transplantation for epithelial ovarian cancer and primary perit…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial update showing Dolastatin 10 in patients with recurrent or metastatic soft tissue sarcoma has completed; ovarian cancer is lis…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Gene Therapy in Treating Patients With Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating a gene therapy for ovarian cancer has completed. The update notes the study status as completed.